Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Cash from Operations (2016 - 2026)

Insight Molecular Diagnostics' Cash from Operations history spans 6 years, with the latest figure at 5545000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 3.63% to 5545000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 22184000.0, a 7.23% decrease, with the full-year FY2025 number at 22184000.0, down 7.23% from a year prior.
  • Cash from Operations hit 5545000.0 in Q4 2025 for Insight Molecular Diagnostics, down from 4502000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for IMDX hit a ceiling of 3769000.0 in Q3 2023 and a floor of 13277000.0 in Q1 2022.
  • Historically, Cash from Operations has averaged 7385350.0 across 5 years, with a median of 6555500.0 in 2023.
  • Biggest five-year swings in Cash from Operations: plummeted 82.9% in 2021 and later surged 66.93% in 2023.
  • Tracing IMDX's Cash from Operations over 5 years: stood at 7065000.0 in 2021, then crashed by 36.56% to 9648000.0 in 2022, then surged by 54.15% to 4424000.0 in 2023, then dropped by 20.95% to 5351000.0 in 2024, then dropped by 3.63% to 5545000.0 in 2025.
  • Business Quant data shows Cash from Operations for IMDX at 5545000.0 in Q4 2025, 4502000.0 in Q3 2025, and 6279000.0 in Q2 2025.